News Overview

Date
Mar 19, 2020

CoronaVirus (SARS-CoV-2) Situation Update: Charité Research Organisation Operational Status

Teaser text CoronaVirus (SARS-CoV-2) situation update: Charité Research Organisation operational status, impact on ongoing study activities, SARS-CoV-2 clinical trial opportunities (19th March 2020) Read more
Date
Feb 27, 2020

Newsletter February 2020 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (February 2020). Read more
Date
Feb 06, 2020

36th annual congress hosted by the German Society for Pharmaceutical Medicine (March 12/13, 2020)

Teaser text Charité Research Organisation will attend the 36th annual congress hosted by the German Society for Pharmaceutical Medicine (DGPharMed) on 12/13 March in Berlin. Read more
Date
Jan 31, 2020

Newsletter January 2020 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (January 2020). Read more
Date
Aug 19, 2019

Charité Research Organisation as German ambassador for medical biotechnology

Teaser text The Charité Research Organisation was honored this year from the GTAI to represent the German market and its companies in the field of medical biotechnology. Read more
Date
May 29, 2019

Unraveling the secrets of the human brain in health and disease - initiation of a clinical study in depression

Teaser text Little is known about how our brains enable us to store memory, to be conscious, to perceive time, and to make decisions – the human brain hides mysteries science still cannot explain. Read more
Date
Apr 18, 2019

International Day of Clinical Trials in the Urania Berlin – the Charité Research Organisation (CRO) is represented

Teaser text I should be the first... !? At some point, a newly developed medicine must be given to a human for the first time. What happens during these first-time-in-human studies... Read more
Date
Mar 15, 2019

Systemic Lupus Erythematosus trial with Charité Research Organisation – head start and rapid enrollment

Teaser text The Charité Research Organisation has – once again – surpassed all expectations by enrolling 4 patients and scheduling another 4 patients within the first two weeks of the study. Read more
Date
Mar 14, 2019

Recruitment at a tearing pace in EMA compliant dose level study in subjects with reduced renal function

Teaser text In an on-going study to test safety and pharmacokinetics of a new treatment, the Charité Research Organisation has successfully included the 24th patient within the first 3 months of the study. Read more
Date
Dec 10, 2018

First patient enrolled in a trial for moderate to severe psoriasis at the Charité Research Organisation

Teaser text We are happy to announce that we have just enrolled the first psoriatic patient in an open-label phase 2a trial, assessing the clinical efficacy and safety of a new, potential treatment. Read more
Date
Oct 30, 2018

Charité – in 2018 again recognised as Germany's best clinic

Teaser text The German journal Focus analysed, reviewed and ranked — for the 7th time in a row — the Charité as the best hospital in Germany. Scores were based on several factors, including the medical and caretaking performance. Read more
Date
Oct 11, 2018

BioJapan 2018 World Business Forum - CRO's in!

Teaser text BioJapan 2018 World Business Forum - BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades. Read more
Date
Aug 14, 2018

Completion of recruitment for a Phase I MS trial

Teaser text Recently we finished recruiting for a Phase I trial in patients with progressive multiple sclerosis. This randomized, double-blind, placebo-controlled study was designed to assess the safety and tolerability of a new biologic as well as the pharmacodynamics...
Read more
Date
Jun 23, 2018

MAD/Phase IIa T2D study publication available

Teaser text As of today you can access a new paper published in The Lancet on 22 June 2018 on a combined multiple-ascending dose (MAD) and Phase IIa study in n=112 patients with controlled type 2 diabetes (HbA1c levels between 6.5–8.5%) via... Read more
Date
Jan 31, 2018

Relocation of Charité Research Organisation's Phase I Unit

Teaser text In January 2018 CRO’s Phase I unit moved from Campus Virchow-Klinikum (CVK) to Campus Mitte at Charité – Universitätsmedizin Berlin. Located at the very heart of Charité’s historic campus, the new facilities underwent extensive modernisation ... Read more
Date
Nov 28, 2017

Phase IIa Sjögren Syndrome Case Study available

Teaser text As of today you can access our first case study that illustrates how - with our help - you can reach Proof of Concept faster. This particular case study deals with a  Phase IIa, single dose, double-blind, placebo-controlled, parallel study to assess the PD, PK ... Read more
Date
Nov 09, 2017

Bacteriophages join the fight against infection

Teaser text (Hannover, Germany) Bacteria worldwide keep developing new resistances to antibiotics. Alternative therapies are urgently needed to meet this challenge. To this end, the Fraunhofer Institute for Toxicology and Experimental ... Read more
Date
Nov 06, 2017

Meet Charité Research at BioEurope 2017

Teaser text Charité Research Organisation will be present at the 2017 BioEurope in Berlin from November 6 to November 8. If you would like to meet, please contact us via enquiries@charite-research.org, +49-30-450 539 211 or the ... Read more